#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3537386	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 12 hrs by mass spectrometry	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
2.	ALA3540347	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
3.	ALA3540348	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
4.	ALA3540349	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 4 hrs by HPLC analysis	Macaca fascicularis	10	ALA3526109	organism-based format	Scientific Literature
5.	ALA3540350	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 6 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
6.	ALA3540351	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 12 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
7.	ALA3538438	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 1 hr by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
8.	ALA3538439	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 2 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
9.	ALA3538440	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 4 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
10.	ALA3538441	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 6 hrs by mass spectrometry	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
11.	ALA3539127	ADME	Percentage unbound in cynomolgus monkey plasma at 1 uM after 5 hrs by equilibrium dialysis	Macaca fascicularis	1	ALA3526097	cell-free format	Scientific Literature
12.	ALA3539128	ADME	Percentage unbound in cynomolgus monkey plasma at 5 uM after 5 hrs by equilibrium dialysis	Macaca fascicularis	1	ALA3526097	cell-free format	Scientific Literature
13.	ALA3539129	ADME	Percentage unbound in cynomolgus monkey plasma at 10 uM after 5 hrs by equilibrium dialysis	Macaca fascicularis	1	ALA3526097	cell-free format	Scientific Literature
14.	ALA3536174	ADME	Metabolic stability in cynomolgus monkey plasma assessed as compound remaining at 5 to 10 uM after 1 hr by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526151	cell-free format	Scientific Literature
15.	ALA3532575	ADME	Unbound fraction in cynomolgus monkey plasma treated with risperidone at 0.1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526130	organism-based format	Scientific Literature
16.	ALA3532578	ADME	AUC(0 to 2 hrs) in cynomolgus monkey plasma at 1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526130	organism-based format	Scientific Literature
17.	ALA3532580	ADME	AUC(0 to 1 hr) in cynomolgus monkey plasma at 0.1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526130	organism-based format	Scientific Literature
18.	ALA3532582	ADME	AUC(0 to 1 hr) in cynomolgus monkey plasma treated with risperidone at 0.1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526130	organism-based format	Scientific Literature
19.	ALA3534752	ADME	Unbound fraction in cynomolgus monkey plasma at 0.1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	2	ALA3526130	organism-based format	Scientific Literature
20.	ALA3534756	ADME	Unbound fraction in cynomolgus monkey plasma at 1 mg/kg, sc by LC-MS/MS analysis	Macaca fascicularis	1	ALA3526130	organism-based format	Scientific Literature